Increased gut permeability in Crohn's disease: is TNF the link?
Open Access
- 1 December 2004
- Vol. 53 (12) , 1724-1725
- https://doi.org/10.1136/gut.2004.047092
Abstract
Intestinal epithelial barrier function and Crohn’s disease are intimately related. An impaired barrier in association with active inflammation leads to increased exposure of the mucosal innate and acquired immune system to proinflammatory molecules. This has been implicated as a major driving force for mucosal inflammation. In active disease, macromolecules can permeate the barrier at an increased rate via, for example, breaks in the integrity of the epithelium (ulceration, erosions, or nests of apoptotic cells)1 via increased pinocytotic uptake of luminal proteins,2, 3 and via increased proportion of M cells in the terminal ileum.4 Impaired barrier function may precede the clinical development of the disease and might represent a marker of increased susceptibility to Crohn’s disease. This notion derives from observations made in several centres using different techniques that paracellular permeability is abnormal in 10–20% of first degree relatives of patients with Crohn’s disease.8, 9, 11 That this reflects exposure to an environmental factor is supported by the observations from three studies that increased intestinal permeability is also found in 13–36% of spouses of patients with Crohn’s disease.8, 9, 11Keywords
This publication has 23 references indexed in Scilit:
- Apoptosis and Intestinal Barrier FunctionAnnals of the New York Academy of Sciences, 2006
- Increased epithelial uptake of protein antigens in the ileum of Crohn's disease mediated by tumour necrosis factorGut, 2004
- Proinflammatory Cytokines Disrupt Epithelial Barrier Function by Apoptosis-Independent MechanismsThe Journal of Immunology, 2003
- Subclinical intestinal inflammation: an inherited abnormality in Crohn’s disease relatives?Gastroenterology, 2003
- Multidrug resistance 1 gene (P-glycoprotein 170): an important determinant in gastrointestinal disease?Gut, 2003
- Glutamine deprivation facilitates tumour necrosis factor induced bacterial translocation in Caco-2 cells by depletion of enterocyte fuel substrateGut, 2003
- Anti-tumor necrosis factor treatment restores the gut barrier in Crohn's diseaseAmerican Journal of Gastroenterology, 2002
- Maintenance infliximab for Crohn's disease: the ACCENT I randomised trialPublished by Elsevier ,2002
- Intestinal permeability in Crohn's disease patients and their first degree relativesDigestive and Liver Disease, 2001
- Intestinal permeability is increased in a proportion of spouses of patients with Crohn's diseaseAmerican Journal of Gastroenterology, 2001